|
|
|
|
GE Healthcare Announces New Compatibility For Fractional Flow Reserve (FFR) Evaluation With The Mac-Lab(R) XT
GE Healthcare, the $17 billion medical technology division of General Electric Company (NYSE:GE), today announced the Mac-Lab's validation of compatibility with the Volcano's SmartMap Pressure Instrument and PrimeWire Pressure Guide Wire for evaluation of...
|
|
|
Sokolove Says Plavix May do More Heart than Good
FDA Black Box Warning Indicates High Risk for Consumers Wellesley, MA (PRWEB) March 19, 2010 -- The FDA announced this week that it has added a black box warning to Plavix (clopidogrel), a widely used blood thinner and anti-clotting drug, because it may cause...
|
|
|
Stow man died from rare cancer
A STOW man died from a rare and aggressive form of cancer, an inquest heard.Clifford Jordan, aged 85, of East View Gardens, Union Street, was a retired congregational church minister. His wife Ann said he had been generally fit and well until Christmas...
|
|
|
Hemodynamic parameters differ in ability to identify atherosclerotic plaque
Atherosclerosis 2010: Advance online publication MedWire News: Hemodynamic parameters differ in their ability to identify sites prone to atherosclerosis in the right coronary artery (RCA), study findings suggest.Oscillatory shear index (OSI) and relative...
|
|
|
Stow man died from rare cancer
A STOW man died from a rare and aggressive form of cancer, an inquest heard.Clifford Jordan, aged 85, of East View Gardens, Union Street, was a retired congregational church minister. His wife Ann said he had been generally fit and well until Christmas...
|
|
|
ACC: Chronic Kidney Disease Patients Fare Well in Statin Trial
Explain that this study appears to show safety of rosuvastatin in patients with chronic kidney disease.Explain that there may be differences between patients with chronic kidney disease and those who have progressed to dialysis who may not benefit from...
|
|
|
Rosuvastatin Reduces Risk of Death in Patients With CKD, Elevated C-Reactive Protein: Presented at ACC
-- Patients with chronic kidney disease (CKD) who have low levels of cholesterol but elevated C-reactive protein appear to markedly reduce their risk of mortality when treated with rosuvastatin, researchers said here at the 59th Annual Scientific Sessions of...
|
|
|
GE Announces New Compatibility for FFR Evaluation
Fractional Flow Reserve helps reduce the risk of a patient dying or suffering a heart attack by 35% in patients with multivessel coronary artery disease undergoing percutaneous coronary intervention GE Healthcare , the $17 billion medical technology division of...
|
|
|
Neovasc Presents Positive Long Term Results from Initial Clinical Study of Its Reducer(TM) Product for Refract
-- Data Presented at the American College of Cardiology 2010 Annual Meeting Suggests Treatment with the Neovasc Reducer Is Safe and Improves Angina Symptoms for at Least Three Years -- TSX Venture Exchange: NVC VANCOUVER Refractory angina is a...
|
|
|
Neovasc Presents Positive Long Term Results from Initial Clinical Study of Its Reducer(TM) Product for Refract
-- Data Presented at the American College of Cardiology 2010 Annual Meeting Suggests Treatment with the Neovasc Reducer Is Safe and Improves Angina Symptoms for at Least Three Years -- TSX Venture Exchange: NVC VANCOUVER and ATLANTA, March 16 /PRNewswire...
|
|
|
Warning Letters for Unapproved Sublingual Nitroglycerin Tablets
The FDA has ordered Glenmark Generics and Konec to stop marketing unapproved sublingual nitroglycerin 0.3, 0.4, and 0.6 mg tablets, indicated for the acute relief of an attack or prophylaxis of angina pectoris caused by coronary artery disease, because...
|
|
|
FDA 'Black Box' Warning on Blood Thinner Plavix
The Food and Drug Administration (FDA) announced a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to...
|
|
|
Woman, 74, left hospital in nightie
Leeds widow sent home from hospital in nightgown The family of a widow from Leeds is demanding an apology after she was discharged from hospital in the middle of the night wearing just a nightgown.Elsie Allanson, 74, was admitted to the city's St James's...
|
|
|
AIM: New study refutes FDA's contraindication for Plavix and PPIs
Heart patients who took proton-pump inhibitors (PPIs) along with clopidogrel were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone.In addition, the PPIs did not inhibit clopidogrels therapeutic...
|
|
|
Variability as well as high blood pressure holds high risk of stroke
Three papers published at the same time in The Lancet, and a further study in The Lancet Neurology, show that it is variability in patients blood pressure that predicts the risk of a stroke most powerfully and not a high average or usual blood pressure level.
|
|
|
Neovasc Reducer three-year follow-up data presented at 2010 ACC annual meeting
-- Data Presented at the American College of Cardiology 2010 Annual Meeting Suggests Treatment with the Neovasc Reducer Is Safe and Improves Angina Symptoms for at Least Three Years -- Neovasc Inc.(TSXV: NVC), a developer of novel technologies used to...
|
|
|
Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Inde
Gerald R.Fowkes, FRCPE; Jacqueline F. Price, MD; Marlene C. Stewart, PhD; Isabella Butcher, PhD; Gillian C. Leng, MD; Alistair C. Pell, MD; Peter A. Sandercock, DM; Keith A. Fox, FRCP; Gordon D. Lowe, DSc; Gordon D. Murray, PhD; for the...
|
|
|
Research and Markets: Atherosclerosis or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
Research and Markets: DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d0f918/atherosclerosis_or) has announced the addition of GlobalData's new report "" to their offering.is an essential source of information and...
|
|
|
ICES study finds many patients with stable angina improve with medicines alone
Toronto - Angioplasty (a procedure used to widen a narrowed or obstructed blood vessel in the heart) may not be the only avenue for stable heart disease patients with chest pain.Although recent studies have shown that angioplasty does not reduce death or...
|
|
|
Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief
Wijeysundera HC et al.In this metaanalysis of angina relief with percutaneous coronary intervention (PCI) versus medical therapy in patients with coronary artery disease, pooled data from 14 randomized trials 1 to 7 years in duration showed that more...
|
|
|
Meta-analysis: Routine Invasive Strategy Holds Long-Term Advantage for ACS
ATLANTA, GAFor patients with non-ST-elevation acute coronary syndromes (NSTE ACS), following a routine invasive strategy reduces the long-term relative risk of death or myocardial infarction (MI) by 19%, according to a meta-analysis presented Sunday, March 14,...
|
|
|
Research and Markets: Target Product Profiles 2009: Physician Insights on Key Attributes: Coronary Heart Disease (Stable Angina)
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/77cbf9/target_product_pro) has announced the addition of Decision Resources, Inc.'s new report "" to their offering.Coronary Heart Disease (Stable Angina): A...
|
|
|
Clopidogrel (Plavix'Bristol-Myers Squibb; sanofi-aventis): Reduced effectiveness in patients who are poor
Audience: Cardiology healthcare professionals, patients [Posted 03/12/2010] FDA notified healthcare professionals and patients that a Boxed Warning has been added to the prescribing information for Plavix, an anti-blood clotting medication.The Boxed Warning...
|
|
|
Cilostazol Improves Platelet Reactivity, Not Clinical Outcomes in DES Patients
ATLANTA, GATriple antiplatelet therapy with cilostazol added to clopidogrel and aspirin lowers platelet reactivity compared with standard dual therapy in patients receiving drug-eluting stents (DES), but these results do not translate to fewer ischemic events,...
|
|
|
FDA strengthens Plavix safety warning
A boxed warning has been added to the US packaging of Sanofi-Aventis and Bristol-Myers Squibbs blockbuster anti-clotting drug Plavix.The US Food and Drug Administration (FDA) imposed the change, which explains the drug can be less effective in people whose...
|
